Comparison

MEISi-2 European Partner

Item no. HY-134259-50mg
Manufacturer MedChem Express
CASRN 2250156-71-7
Amount 50 mg
Quantity options 100 mg 10 mM * 1 mL 10 mg 50 mg 5 mg
Category
Type Inhibitor
Specific against other
Purity 99.12
Formula C18H14N2O3
Citations [1]Raife Dilek Turan, et al. Development of Small Molecule MEIS Inhibitors that modulate HSC activity. Sci Rep. 2020; 10: 7994.
Smiles O=C(NN/C=C1C(C=CC2=C\1C=CC=C2)=O)C3=CC=C(O)C=C3
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
MEISi-2 is a selective inhibitor of MEIS, a key regulator of hematopoietic stem cell (HSC) self-renewal. MEISi-2 is developed for the research of cardiac injuries, hematopoiesis issues, bone marrow transplantations, and cancer[1].
StorageTemperature
-20°C, 3 years (Powder)
Shipping
Blue Ice
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
306.32
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
DMSO : 1 mg/mL (ultrasonic; warming; heat to 60°C)|H2O : 1 mg/mL (ultrasonic; warming; heat to 60°C)
Target
Others
Manufacturers Target
Others
Manufacturers Pathway
Others
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close